NSE - Delayed Quote INR
AKUMS DRUGS AND PHARMA L (AKUMS.NS)
507.00
+2.55
+(0.51%)
At close: 3:29:58 PM GMT+5:30
Research Analysis
Earnings Estimate
| Currency in INR | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 3 | 3 |
| Avg. Estimate | 4.3 | 0 | 17.35 | 22.71 |
| Low Estimate | 4.3 | 0 | 16.85 | 22.04 |
| High Estimate | 4.3 | 0 | 17.7 | 23.1 |
| Year Ago EPS | -- | -- | -- | 17.35 |
Revenue Estimate
| Currency in INR | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 3 | 3 |
| Avg. Estimate | 10.25B | -- | 40.8B | 45.27B |
| Low Estimate | 10.25B | -- | 40.6B | 44.33B |
| High Estimate | 10.25B | -- | 40.92B | 45.84B |
| Year Ago Sales | -- | -- | -- | 40.8B |
| Sales Growth (year/est) | -- | -- | -- | 10.95% |
Earnings History
| Currency in INR | 12/31/2024 |
|---|---|
| EPS Est. | -- |
| EPS Actual | 4.26 |
| Difference | -- |
| Surprise % | -- |
EPS Trend
| Currency in INR | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 4.3 | 0 | 17.35 | 22.71 |
| 7 Days Ago | 0 | 0 | 17.8 | 22.71 |
| 30 Days Ago | 0 | 0 | 17.7 | 23.05 |
| 60 Days Ago | 0 | 0 | 17.4 | 22.25 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in INR | Current Qtr. (Mar 2025) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AKUMS.NS | -- | -- | -- | 30.90% |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Related Tickers
ZYDUSLIFE.BO Zydus Lifesciences Limited
884.65
+0.77%
SUVEN.NS Suven Life Sciences Limited
153.07
+7.46%
AUROPHARMA.NS Aurobindo Pharma Limited
1,205.90
+3.56%
GLENMARK.NS Glenmark Pharmaceuticals Limited
1,381.70
-1.18%
CIPLA.NS Cipla Limited
1,511.60
+2.14%
MOREPENLAB.NS Morepen Laboratories Limited
60.36
+7.10%
ZYDUSLIFE.NS Zydus Lifesciences Limited
884.85
+0.71%
SEQUENT.NS Sequent Scientific Limited
169.22
+5.02%
LUPIN.NS Lupin Limited
2,039.80
+0.12%
AARTIDRUGS.NS Aarti Drugs Limited
428.40
+2.33%